JP2022540768A5 - - Google Patents

Info

Publication number
JP2022540768A5
JP2022540768A5 JP2021576605A JP2021576605A JP2022540768A5 JP 2022540768 A5 JP2022540768 A5 JP 2022540768A5 JP 2021576605 A JP2021576605 A JP 2021576605A JP 2021576605 A JP2021576605 A JP 2021576605A JP 2022540768 A5 JP2022540768 A5 JP 2022540768A5
Authority
JP
Japan
Application number
JP2021576605A
Other languages
Japanese (ja)
Other versions
JPWO2020263651A5 (https=
JP2022540768A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/038116 external-priority patent/WO2020263651A1/en
Publication of JP2022540768A publication Critical patent/JP2022540768A/ja
Publication of JP2022540768A5 publication Critical patent/JP2022540768A5/ja
Publication of JPWO2020263651A5 publication Critical patent/JPWO2020263651A5/ja
Pending legal-status Critical Current

Links

JP2021576605A 2019-06-27 2020-06-17 骨髄細胞炎症性表現型を調節するための抗cd53組成物及び方法、ならびにその使用 Pending JP2022540768A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962867602P 2019-06-27 2019-06-27
US62/867,602 2019-06-27
PCT/US2020/038116 WO2020263651A1 (en) 2019-06-27 2020-06-17 Anti-cd53 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof

Publications (3)

Publication Number Publication Date
JP2022540768A JP2022540768A (ja) 2022-09-20
JP2022540768A5 true JP2022540768A5 (https=) 2023-06-26
JPWO2020263651A5 JPWO2020263651A5 (https=) 2023-06-26

Family

ID=74060343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021576605A Pending JP2022540768A (ja) 2019-06-27 2020-06-17 骨髄細胞炎症性表現型を調節するための抗cd53組成物及び方法、ならびにその使用

Country Status (10)

Country Link
US (1) US20220251233A1 (https=)
EP (1) EP3990015A4 (https=)
JP (1) JP2022540768A (https=)
KR (1) KR20220042128A (https=)
CN (1) CN114728057A (https=)
AU (1) AU2020304415A1 (https=)
BR (1) BR112021026181A2 (https=)
CA (1) CA3142840A1 (https=)
IL (1) IL289171A (https=)
WO (1) WO2020263651A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102616360B1 (ko) * 2021-11-09 2023-12-27 재단법인 아산사회복지재단 염증성 근육병증 진단용 바이오마커 조성물
CN116380755B (zh) * 2023-03-20 2023-11-21 广州市第一人民医院(广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院) CD127+PMN-MDSCs在诊断支气管肺发育不良中的应用及诊断试剂盒
WO2024220870A1 (en) * 2023-04-19 2024-10-24 The University Of Chicago Antibody-targeted enzymatic chemoprotection
CN117816128B (zh) * 2023-12-15 2025-11-25 华南农业大学 一种重金属检测-吸附一体化复合材料及其制备方法与应用
JP7720659B1 (ja) * 2024-11-15 2025-08-08 宜広 磯貝 骨感染症の血漿バイオマーカー

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100206524B1 (ko) * 1990-07-13 1999-07-01 어니스트 엠. 해데드 씨디 53 세포 표면 항원 및 그를 암호화하는 재조합 디엔에이
WO2002072861A1 (en) * 2001-03-08 2002-09-19 Incyte Genomics, Inc. Cd53 cell surface antigen
US7674598B2 (en) * 2004-05-21 2010-03-09 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential
CN101583722A (zh) * 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 从生物学样品检测稀有细胞的方法和组合物
JP7078533B2 (ja) * 2015-10-21 2022-05-31 オーエスイー イムノセラピューティクス 炎症促進性細胞へのマクロファージ分極を改変して癌を治療するための抗SIRPa化合物
JP6967528B2 (ja) * 2016-04-04 2021-11-17 バイオベラティブ ユーエスエー インコーポレイテッド 抗補体Bb因子抗体及びその使用
US20190161542A1 (en) * 2016-08-01 2019-05-30 Novartis Ag Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage molecule
CN111527105B (zh) * 2017-10-11 2024-10-25 美国比奥维拉迪维股份有限公司 诱导补体活性的方法
JP2021529753A (ja) * 2018-06-29 2021-11-04 ヴェルソー セラピューティクス, インコーポレイテッド 単球及びマクロファージの炎症性表現型を調節するための組成物及び方法、ならびにそれを使用する免疫療法

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2022540768A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2022539038A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)